Schonfeld Strategic Advisors’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-22,736
Closed -$489K 2468
2025
Q3
$489K Buy
22,736
+9,127
+67% +$207K ﹤0.01% 1697
2025
Q2
$299K Sell
13,609
-70,494
-84% -$1.55M ﹤0.01% 1689
2025
Q1
$1.88M Buy
+84,103
New +$1.81M 0.01% 989
2024
Q4
Sell
-28,500
Closed -$478K 2296
2024
Q3
$478K Buy
+28,500
New +$684K ﹤0.01% 1455
2024
Q2
Sell
-10,699
Closed -$408K 2469
2024
Q1
$408K Buy
+10,699
New +$404K ﹤0.01% 1546
2023
Q4
Sell
-24,900
Closed -$847K 2145
2023
Q3
$847K Sell
24,900
-36,856
-60% -$1.39M 0.01% 1067
2023
Q2
$2.43M Sell
61,756
-18,344
-23% -$662K 0.02% 690
2023
Q1
$2.57M Buy
80,100
+55,806
+230% +$1.84M 0.02% 619
2022
Q4
$757K Sell
24,294
-31,752
-57% -$1.15M 0.01% 1302
2022
Q3
$2.08M Buy
56,046
+3,486
+7% +$131K 0.02% 837
2022
Q2
$1.53M Buy
+52,560
New +$1.88M 0.01% 834
2021
Q4
Sell
-4,303
Closed -$241K 2437
2021
Q3
$241K Buy
+4,303
New +$238K ﹤0.01% 1673
2020
Q4
Sell
-30,000
Closed -$883K 1802
2020
Q3
$883K Buy
+30,000
New +$827K 0.02% 731

Other funds holding PGNY

Schonfeld Strategic Advisors's PGNY Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of Progyny (PGNY) in Q4 2025, closing a stake of 22,736 shares — an estimated $489K sold.

Schonfeld Strategic Advisors first reported a position in PGNY in Q3 2020 and held it in 13 quarters. The position peaked at $2.57M in Q1 2023. 313 funds tracked by Wall St. Rank hold PGNY as of Q4 2025.

  • Schonfeld Strategic Advisors reported no remaining Progyny position as of Q4 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 22,736 Progyny shares in Q4 2025, an estimated $489K.
  • Schonfeld Strategic Advisors first reported a position in Progyny in Q3 2020 and held it in 13 quarters.
  • Schonfeld Strategic Advisors's Progyny position peaked at $2.57M in Q1 2023.
  • 313 funds tracked by Wall St. Rank held Progyny as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.